Sequencing of the NPAS3 genes of these patients, and in particular those with NPAS3 in their serum and a family history of mental illness, would be an exciting next step in assessing the clinical relevance of these findings, although regrettably, this is not currently possible for us due to the ongoing COVID-19 pandemic. This evidence concerns the gene NPAS3 and psychiatric disorder.